4th Quarter - Report

WILLIAMS AND JENSEN, PLLC for PHRMA

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

General education about policies impacting pharmaceutical development, approval and reimbursement; Non-interference. Medicare Part D. Importation. 340B Drug Pricing Program. CMMI Medicare Part B Demonstration. H.R. 6, Support for Patients and Communities Act.

LobbyistCovered position, as disclosed
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA —
CHERYL LYNN JAEGER —
KARINA LYNCH —
ERIN BOOK MULLEN —
GEORGE OLSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6 (115th)

Budget/Appropriations BUD

Issues related to pharmaceutical development. Policies impacting Medicare Part D; H.R. 6157 FY 2019 Appropriations.

LobbyistCovered position, as disclosed
SUSAN HIRSCHMANN COS, Rep Van Hilleary and Majority Whip
MATTHEW B HOEKSTRA —
CHERYL LYNN JAEGER Shrd employee, Ofc of the Speaker & Ofc of VA 7; Sr Policy Adv, Maj Leader, Rep Cantor; Sr. Policy Adv, Republican Whip, Rep Cantor; Sr. Policy Adv, Maj Whip, Rep Roy Blunt; Prof Staff House Committee E&C; SR LA Rep Cox.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6157 (115th)

Health Issues HCR

General education about policies impacting pharmaceutical development, approval and reimbursement; Non-interference. Rebates for Medicare Part D. Importation. 340B Drug Pricing Program. CMMI Medicare Part B Demonstration; Right to Try; H.R. 1231, RACE for Children Act. Independent Payment Advisory Board. Legislation to address opioid addiction and treatment, including H.R. 6 Support for Patients and Communities Act.

LobbyistCovered position, as disclosed
CHRISTOPHER W HATCHER Sc. C, Treasury; LD, Rep Mcinnis
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA —
CHERYL LYNN JAEGER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1231 (115th), H.R. 6 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.